Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Companyâs services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
äŒæ¥ã³ãŒãDGX
äŒç€ŸåQuest Diagnostics Inc
äžå Žæ¥Dec 17, 1996
æé«çµå¶è²¬ä»»è
ãCEOãDavis (James E)
åŸæ¥å¡æ°45000
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Dec 17
æ¬ç€Ÿæåšå°500 Plaza Drive
éœåžSECAUCUS
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited States of America
éµäŸ¿çªå·07094
é»è©±çªå·19735202700
ãŠã§ããµã€ãhttps://www.questdiagnostics.com/
äŒæ¥ã³ãŒãDGX
äžå Žæ¥Dec 17, 1996
æé«çµå¶è²¬ä»»è
ãCEOãDavis (James E)